Harrow (HROW) Assets (2010 - 2026)
Harrow (HROW) posted Assets of $416.8 million for Q2 2026, down 0.65% on a QoQ basis from $419.5 million in Q1 2026, and up 20.8% year-over-year from $345.0 million in Q2 2025.
Analysis
Harrow (HROW) Assets (2010 - 2026) Analysis & Trends
Harrow has reported Assets for 17 years, with the latest figure at $416.8 million in Q2 2026.
- On a quarterly basis, Assets rose 20.8% year-over-year to $416.8 million in Q2 2026; TTM through Jun 2026 was $416.8 million, a 20.8% increase from a year earlier, with the FY2025 full-year figure at $399.5 million, up 2.7% from the prior year.
- Assets was $416.8 million for Q2 2026 at Harrow, down from $419.5 million in the prior quarter.
- The five-year high for Assets was $419.5 million in Q1 2026, with the low at $97.6 million in Q1 2022.
- Average Assets over 5 years is $285.7 million, with a median of $309.4 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Assets slipped 8.32% in 2022, then jumped 188.98% in 2023.
- Over 5 years, Assets stood at $157.4 million in 2022, then jumped by 98.35% to $312.2 million in 2023, then gained by 24.6% to $389.0 million in 2024, then rose by 2.7% to $399.5 million in 2025, then grew by 4.34% to $416.8 million in 2026.
- The last three Assets figures came in at $416.8 million (Q2 2026), $419.5 million (Q1 2026), and $399.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 150.01 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 4.32 Bn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 7.87 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 7.22 Bn |
| 10 | Harrow | 1.41 Bn | 1.33 Bn | 50.36 Mn | 416.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416.82 Mn |
| Mar 31, 2026 | 419.54 Mn |
| Dec 31, 2025 | 399.48 Mn |
| Sep 30, 2025 | 363.07 Mn |
| Jun 30, 2025 | 345.03 Mn |
| Mar 31, 2025 | 364.16 Mn |
| Dec 31, 2024 | 388.97 Mn |
| Sep 30, 2024 | 351.54 Mn |
| Jun 30, 2024 | 306.63 Mn |
| Mar 31, 2024 | 295.54 Mn |
| Dec 31, 2023 | 312.16 Mn |
| Sep 30, 2023 | 286.07 Mn |
| Jun 30, 2023 | 223.99 Mn |
| Mar 31, 2023 | 217.50 Mn |
| Dec 31, 2022 | 157.38 Mn |
| Sep 30, 2022 | 98.99 Mn |
| Jun 30, 2022 | 98.06 Mn |
| Mar 31, 2022 | 97.60 Mn |
| Dec 31, 2021 | 98.33 Mn |
| Sep 30, 2021 | 102.80 Mn |